Applied BioCode Corporation (6598.TW) TAI

Currency In TWD

AD

Valuation

Market Cap2.26B
Enterprise Value1.85B
P/E Ratio-21.2
PEG Ratio-0.41
Price/Sales Ratio5.41
Price/Book Ratio4.67
Enterprise/Revenue4.75
Enterprise/EBITDA-23.71

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.25
Operating Margin-0.28
AD

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.21

Income Statement

Revenue475.2M
Revenue/Share5.46
Gross Profit260.89M
EBITDA-166.96M
Net Income-201.2M
Diluted EPS-1.96

Balance Sheet

Total Cash542.48M
Total Cash/Share5.17
Total Debt55.83M
Total Debt/Equity0.08
Current Ratio6.02
Book Value Per Share6.44

Price History

52-Week Change52.02
52-Week High31.3
52-Week Low19.15
Moving Average 50 Days24.99
Moving Average 200 Days23.53

Statistics

Average Volume353,835
Shares Outstanding102.82M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor529:500
Last Split DateJuly 02, 2024
AD